| 000 | 01466 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514052334.0 | ||
| 264 | 0 | _c20030102 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/345369 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacobson, Mark A | |
| 245 | 0 | 0 |
_aAssociation of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cDec 2002 |
||
| 300 |
_a1701-2; author reply 1702-3 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _ximmunology |
| 650 | 0 | 4 |
_aAntigens, CD _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Differentiation, T-Lymphocyte _ximmunology |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus Retinitis _ximmunology |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity |
| 650 | 0 | 4 | _aLectins, C-Type |
| 650 | 0 | 4 |
_aLymphocyte Activation _ximmunology |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aBredt, Barry M | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 186 _gno. 11 _gp. 1701-2; author reply 1702-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/345369 _zAvailable from publisher's website |
| 999 |
_c12254093 _d12254093 |
||